Finance Watch: Lucky Few Raise Cash While Many Public Biotechs Cut Costs

Restructuring Ongoing As Firms Extend Funding Runways

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.